CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies

NCT03559439 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

9

Enrollment

OTHER

Sponsor class

Conditions

B-cell Malignancy
B-cell Lymphoma
B-Cell Acute Lymphoblastic Leukaemia

Interventions

BIOLOGICAL: CD19 CAR T

Sponsor

Shanghai Tong Ren Hospital

Collaborators

[object Object]